UBS Group’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
7,795
+2,375
| +44% | +$67.4K | ﹤0.01% | 5418 |
|
|
2025
Q1 | $167K | Sell |
5,420
-1,051
| -16% | -$32.4K | ﹤0.01% | 5412 |
|
|
2024
Q4 | $215K | Buy |
6,471
+3,190
| +97% | +$106K | ﹤0.01% | 5211 |
|
|
2024
Q3 | $99.2K | Buy |
3,281
+1,842
| +128% | +$55.7K | ﹤0.01% | 5189 |
|
|
2024
Q2 | $40.6K | Sell |
1,439
-2,620
| -65% | -$73.9K | ﹤0.01% | 5700 |
|
|
2024
Q1 | $150K | Sell |
4,059
-332
| -8% | -$12.3K | ﹤0.01% | 4882 |
|
|
2023
Q4 | $180K | Buy |
4,391
+2,124
| +94% | +$87.3K | ﹤0.01% | 4656 |
|
|
2023
Q3 | $70.6K | Sell |
2,267
-437
| -16% | -$13.6K | ﹤0.01% | 4953 |
|
|
2023
Q2 | $108K | Buy |
2,704
+2,095
| +344% | +$84K | ﹤0.01% | 4900 |
|
|
2023
Q1 | $25.1K | Buy |
609
+354
| +139% | +$14.6K | ﹤0.01% | 5821 |
|
|
2022
Q4 | $11.6K | Buy |
255
+55
| +28% | +$2.5K | ﹤0.01% | 7185 |
|
|
2022
Q3 | $6K | Sell |
200
-207
| -51% | -$6.21K | ﹤0.01% | 7954 |
|
|
2022
Q2 | $8K | Buy |
+407
| New | +$8K | ﹤0.01% | 7304 |
|
|
2022
Q1 | – | Sell |
-905
| Closed | -$27K | – | 9573 |
|
|
2021
Q4 | $27K | Buy |
905
+330
| +57% | +$9.85K | ﹤0.01% | 6391 |
|
|
2021
Q3 | $20K | Buy |
+575
| New | +$20K | ﹤0.01% | 6023 |
|
|
2021
Q1 | – | Sell |
-369
| Closed | -$18K | – | 8195 |
|
|
2020
Q4 | $18K | Buy |
+369
| New | +$18K | ﹤0.01% | 6003 |
|